For the Inventor, By the Inventor

Enter assignee name

Seoul, South Korea

Ubix Therapeutics, Inc.

USPTO Granted Patents = 2

Forward Citations = 0

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Song Hee Lee (2 out of 3 patents)

Ji Youn Park (2 out of 2 patents)

Je Ho Ryu (2 out of 2 patents)

4. Ho Hyun Lee (2 out of 2 patents)

5. Jung Min Ahn (2 out of 2 patents)

6. Sung Yun Cho (1 out of 14 patents)

7. Jong Yeon Hwang (1 out of 10 patents)

8. Jae Du Ha (1 out of 10 patents)

9. Pil Ho Kim (1 out of 5 patents)

10. Chi Hoon Park (1 out of 9 patents)

11. Hyun Jin Kim (1 out of 11 patents)

12. Ji Young Kim (1 out of 4 patents)

13. Ye Seul Lim (1 out of 1 patent)

14. Hee Jung Moon (1 out of 1 patent)

15. Beom Seon Suh (1 out of 1 patent)

2 patents: Sort by Forward Citations

1. 12161722 - Bifunctional heterocyclic compound having BTK degradation function via ubiquitin proteasome pathway, and use thereof (2024-12-10),

2. 12122763 - Substituted piperidines for androgen receptor degradation (2024-10-22),

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

2 Patents

#1,166 in Seoul

#3,600 in South Korea

Seoul, South Korea

Ubix Therapeutics, Inc.

Forward Citations = 0

21 inventors:

Song Hee Lee (2 out of 3 patents)

Ji Youn Park (2 out of 2 patents)

Je Ho Ryu (2 out of 2 patents)

4. Ho Hyun Lee (2 out of 2 patents)

5. Jung Min Ahn (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com

Loading…